Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-17

Clinical Trial Update: Occipital Nerve Stimulation in the Treatment of Migraine [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating occipital nerve stimulation for migraine has been terminated, indicating the study is no longer ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ethicon, Inc. | Conditions: Migraine | Phase 1 | Status: TERMINATED